Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wolff

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Scientific Reports|February 18, 2016
Long-term safety and stability of angiogenesis induced by balanced single-vector co-expression of PDGF-BB and VEGF164 in skeletal muscleRoberto Gianni-Barrera, Maximilian Burger, Thomas Wolff, et al.
Swiss Medical Weekly|September 6, 2017
Right retroperitoneoscopic living donor nephrectomy does not increase surgical complications in the recipient and leads to excellent long-term outcomeMaria Johanna Schaumeier, Alexandra Nagy, Salome Dell-Kuster, et al.
Carcinogenesis|February 14, 2003
CYP1B1 determines susceptibility to low doses of 7,12-dimethylbenz[a]anthracene-induced ovarian cancers in mice: correlation of CYP1B1-mediated DNA adducts with carcinogenicityJeroen Buters, Leticia Quintanilla-Martinez, Wolfgang Schober, et al.
Journal of Cellular and Molecular Medicine|March 23, 2011
FACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemiaThomas Wolff, Edin Mujagic, Roberto Gianni-Barrera, et al.
In Vivo (Athens, Greece)|September 3, 2020
Arteriovenous Loops Enable Free Tissue Transfer With Otherwise Inadequate Local Donor and Recipient VesselsMathias Tremp, Carlo M Oranges, Thomas Wolff, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|February 16, 2007
Primary care providers' perceptions of home diabetes telemedicine care in the IDEATel projectFred Tudiver, L Thomas Wolff, Philip C Morin, et al.
Annals of Hematology|February 29, 2024
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe studyIngo Schwaner, Thomas Kuhn, Christoph Losem, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 11, 2019
Ultrasound Molecular Imaging of Atherosclerosis With Nanobodies: Translatable Microbubble Targeting Murine and Human VCAM (Vascular Cell Adhesion Molecule) 1Mukesh Punjabi, Lifen Xu, Amanda Ochoa-Espinosa, et al.
Clinical Kidney Journal|April 16, 2015
The outcome of the primary vascular access and its translation into prevalent access use rates in chronic haemodialysis patientsClaudia Praehauser, Tobias Breidthardt, Cora Nina Moser-Bucher, et al.
Transplantation|June 18, 2019
Differential Impact of Delayed Graft Function in Deceased Donor Renal Transplant Recipients With and Without Donor-specific HLA-antibodiesJana Haller, Caroline Wehmeier, Gideon Hönger, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Scientific Reports|February 18, 2016
Long-term safety and stability of angiogenesis induced by balanced single-vector co-expression of PDGF-BB and VEGF164 in skeletal muscleRoberto Gianni-Barrera, Maximilian Burger, Thomas Wolff, et al.
Swiss Medical Weekly|September 6, 2017
Right retroperitoneoscopic living donor nephrectomy does not increase surgical complications in the recipient and leads to excellent long-term outcomeMaria Johanna Schaumeier, Alexandra Nagy, Salome Dell-Kuster, et al.
Carcinogenesis|February 14, 2003
CYP1B1 determines susceptibility to low doses of 7,12-dimethylbenz[a]anthracene-induced ovarian cancers in mice: correlation of CYP1B1-mediated DNA adducts with carcinogenicityJeroen Buters, Leticia Quintanilla-Martinez, Wolfgang Schober, et al.
Journal of Cellular and Molecular Medicine|March 23, 2011
FACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemiaThomas Wolff, Edin Mujagic, Roberto Gianni-Barrera, et al.
In Vivo (Athens, Greece)|September 3, 2020
Arteriovenous Loops Enable Free Tissue Transfer With Otherwise Inadequate Local Donor and Recipient VesselsMathias Tremp, Carlo M Oranges, Thomas Wolff, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|February 16, 2007
Primary care providers' perceptions of home diabetes telemedicine care in the IDEATel projectFred Tudiver, L Thomas Wolff, Philip C Morin, et al.
Annals of Hematology|February 29, 2024
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe studyIngo Schwaner, Thomas Kuhn, Christoph Losem, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 11, 2019
Ultrasound Molecular Imaging of Atherosclerosis With Nanobodies: Translatable Microbubble Targeting Murine and Human VCAM (Vascular Cell Adhesion Molecule) 1Mukesh Punjabi, Lifen Xu, Amanda Ochoa-Espinosa, et al.
Clinical Kidney Journal|April 16, 2015
The outcome of the primary vascular access and its translation into prevalent access use rates in chronic haemodialysis patientsClaudia Praehauser, Tobias Breidthardt, Cora Nina Moser-Bucher, et al.
Transplantation|June 18, 2019
Differential Impact of Delayed Graft Function in Deceased Donor Renal Transplant Recipients With and Without Donor-specific HLA-antibodiesJana Haller, Caroline Wehmeier, Gideon Hönger, et al.
Pageof 10